<PAGE>
CUSIP No. 62936P-10-3 Page 1 of 5
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)
NPS Pharmaceuticals, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.001 par value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
62936P-10-3
- --------------------------------------------------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ].
<PAGE>
Page 2 of 5
- --------------------------------------------------------------------------------
1) Name of Reporting Person Hunter Jackson
S.S. or I.R.S. Identification
No. of Above Person
- --------------------------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- --------------------------------------------------------------------------------
3) SEC Use Only
- --------------------------------------------------------------------------------
4) Citizenship or Place of United States
Organization
- --------------------------------------------------------------------------------
Number of Shares 5) Sole Voting Power 323,176 shares of Common
Beneficially Owned by Stock, $.001 par value
Each Reporting Person ("COMMON STOCK")
With -------------------------------------------------------
6) Shared Voting Power 75,002 shares of Common
Stock
-------------------------------------------------------
7) Sole Dispositive 323,176 shares of Common
Power Stock
-------------------------------------------------------
8) Shared Dispositive 75,002 shares of Common
Power Stock
-------------------------------------------------------
9) Aggregate Amount Beneficially 551,578 shares of Common
Owned by Each Reporting Person Stock (Includes options:
See Footnote 1 on Page 4
of 5)
- --------------------------------------------------------------------------------
10) Check if the Aggregate Amount
in Row (9) Excludes Certain
Shares [ ]
- --------------------------------------------------------------------------------
11) Percent of Class Represented 4.67% (based on 11,807,220
by Amount in Row 9 shares outstanding as of
December 31, 1996)
- --------------------------------------------------------------------------------
12) Type of Reporting Person IN
- --------------------------------------------------------------------------------
<PAGE>
Page 3 of 5
SCHEDULE 13G
Item 1(a). NAME OF ISSUER:
NPS Pharmaceuticals, Inc.
Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
420 Chipeta Way
Salt Lake City, Utah 84108
Item 2(a). NAME OF PERSON FILING:
Hunter Jackson
Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
420 Chipeta Way
Salt Lake City, Utah 84108
Item 2(c). CITIZENSHIP:
United States
Item 2(d). TITLE OF CLASS OF SECURITIES:
Common Stock, $.001 par value
Item 2(e). CUSIP NUMBER:
62936P-10-3
Item 3. Not applicable.
<PAGE>
Page 4 of 5
Item 4. OWNERSHIP.
(a) Amount beneficially owned: 551,578(1)
(b) Percent of class: 4.67% (based on 11,807,221 shares outstanding
as of December 31, 1996)
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote: 323,176
(ii) Shared power to vote or to direct the vote: 75,002
(iii) Sole power to dispose or to direct the disposition
of: 323,176
(iv) Shared power to dispose or to direct the disposition of:
75,002
Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities, check the
following [ X ].
Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
None.
Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not applicable.
Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable.
Item 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
- -------------------
(1) Includes 2 shares held by the reporting person's children and 75,000
shares held in a trust. The reporting person disclaims beneficial ownership
of such securities. Also includes 153,400 shares issuable upon exercise of
options within 60 days of December 31, 1996.
<PAGE>
Page 5 of 5
Item 10. CERTIFICATION.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary
course of business and were not acquired for the purpose of and do not
have the effect of changing or influencing the control of the issuer
of such securities and were not acquired in connection with or as a
participant in any transaction having such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February , 1997
------------------------------
(Date)
/s/ Hunter Jackson
------------------------------
(Signature)
Hunter Jackson, CEO, President
and Chairman of the Board
------------------------------
(Name and Title)
